Postmenopausal hormone therapy use declines amidst risk-benefit concerns

A study reveals a sharp decline in menopausal hormone therapy use among U.S. women, highlighting disparities across racial and ethnic groups over two decades.

Eisai and Biogen win approval for once-monthly Leqembi maintenance dosing

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

January 27, 2025

IMIDomics partners with UB to advance IMIDs treatments

IMIDomics will utilise the technology and expertise of the University of Barcelona to progress its drug targets through research projects. Credit: Gorodenkoff/Shutterstock.com. IMIDomics has entered

October 12, 2023

The Biggest Psychedelic News This Week: November 6 – 10 | Psychedelic Spotlight

As researchers investigate the potential of psilocybin in cancer patients and LSD as treatment for ADHD, the psychedelic ecosystem witnesses more acquisitions, patents, and decriminalization

November 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.